S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
TSE:NBLY

Neighbourly Pharmacy (NBLY) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
C$18.20
C$18.60
52-Week Range
N/A
Volume
816,808 shs
Average Volume
283,112 shs
Market Capitalization
C$835.51 million
P/E Ratio
N/A
Dividend Yield
0.98%
Price Target
C$20.93

Neighbourly Pharmacy MarketRank™ Stock Analysis

Analyst Rating
Hold
2.40 Rating Score
Upside/​Downside
∞ Upside
C$20.93 Price Target
Short Interest
N/A
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
C$1.16 M Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.63 out of 5 stars

NBLY stock logo

About Neighbourly Pharmacy Stock (TSE:NBLY)

Neighbourly Pharmacy Inc. owns and operates a chain of retail pharmacies in Canada. The company sells prescription medication, confections and food, over the counter drugs, and health and beauty aids. It operates pharmacies under the various banners, such as IDA/Guardian, Pharmachoice, Pharmasave, Remedy's RX, and Drug Trading. The company was incorporated in 2015 and is headquartered in Toronto, Canada.

NBLY Stock News Headlines

Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Did you make $29,000 two days with AI options trades?
What if it was possible to find options trades on autopilot… Using A.I. to find the ones with the highest profit potential… And nearly perfect win rates… You can grab your free copy of my "Ultimate Guide to A.I. Options Trading" by clicking the link below:
Neighbourly Pharmacy Inc. (NBLY.TO)
When Will Neighbourly Pharmacy Inc. (TSE:NBLY) Breakeven?
Neighbourly Announces Strong Third Quarter Results
Closing Bell: Neighbourly Pharmacy Inc up on Wednesday (NBLY)
See More Headlines
Receive NBLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neighbourly Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today
3/29/2024
Next Earnings (Estimated)
6/06/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical Retailers
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
3,648
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
C$20.93
High Stock Price Target
C$28.00
Low Stock Price Target
C$18.50
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

Net Income
C$-32,700,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$874.61 million
Book Value
C$13.07 per share

Miscellaneous

Free Float
N/A
Market Cap
C$835.51 million
Optionable
Not Optionable
Beta
0.29
7 Stocks to Own Before the 2024 Election Cover

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

  • Mr. Skip Bourdo (Age 46)
    CEO & Director
    Comp: $604.17k
  • Mr. Billy Wong C.M.A.
    CPA, M.B.A., Chief Financial Officer
  • Mr. Jari Pekka Villanen (Age 53)
    Senior Vice President of Integration, Real Estate & Central Operations
    Comp: $307.48k
  • Mr. Steve Losty (Age 50)
    Chief Development Officer
    Comp: $302.15k
  • Ms. Maura Dyer
    Senior Vice President of People & Culture
  • Ms. Alicia Matthews-Kent
    Senior Vice President of Pharmacy Strategy & National Operations
  • Mr. Zev Zelman
    Corporate Secretary

NBLY Stock Analysis - Frequently Asked Questions

Should I buy or sell Neighbourly Pharmacy stock right now?

5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Neighbourly Pharmacy in the last year. There are currently 3 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NBLY shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NBLY, but not buy additional shares or sell existing shares.
View NBLY analyst ratings
or view top-rated stocks.

What is Neighbourly Pharmacy's stock price target for 2024?

5 brokers have issued 1-year target prices for Neighbourly Pharmacy's shares. Their NBLY share price targets range from C$18.50 to C$28.00. On average, they expect the company's share price to reach C$20.93 in the next year.
View analysts price targets for NBLY
or view top-rated stocks among Wall Street analysts.

When is Neighbourly Pharmacy's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 6th 2024.
View our NBLY earnings forecast
.

How often does Neighbourly Pharmacy pay dividends? What is the dividend yield for Neighbourly Pharmacy?

Neighbourly Pharmacy announced a quarterly dividend on Monday, November 20th. Shareholders of record on Tuesday, December 19th will be paid a dividend of 0.045 per share on Tuesday, December 19th. This represents a $0.18 dividend on an annualized basis and a yield of ∞. The ex-dividend date is Monday, November 20th.
Read our dividend analysis for NBLY
.

Is Neighbourly Pharmacy a good dividend stock?

Neighbourly Pharmacy (TSE:NBLY) pays an annual dividend of C$0.18 per share and currently has a dividend yield of 0.98%.
Read our dividend analysis for NBLY.

How do I buy shares of Neighbourly Pharmacy?

Shares of NBLY stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (TSE:NBLY) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners